Cite Filings / MIRM / 0001193805-20-000192
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Mirum Pharmaceuticals, Inc. · Filed 2020-02-13 · Acc 0001193805-20-000192

Documents 1

  • SC 13G/A Amended Statement of Ownership , e619356_sc13ga-mirum.htm

Around this filing

  • 2020-02-14 SC 13G/A Amended Statement of Ownership
  • 2020-02-13 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 8.5%
  2. 2026-08-13 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 9.7%
  3. 2026-08-06 SCHEDULE 13G · FMR LLC 6.2%
  4. 2026-04-27 SCHEDULE 13G/A · BlackRock, Inc. 5.7%
  5. 2026-03-27 SCHEDULE 13G/A · The Vanguard Group 0%
  6. 2026-02-17 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 11.8%
  7. 2026-02-13 SCHEDULE 13G/A · Eventide Asset Management, LLC 4.1%
  8. 2026-01-27 SCHEDULE 13D/A · Patrick J. Heron 6.8%
  9. 2025-12-05 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 10.6%
  10. 2025-11-14 SCHEDULE 13G/A · JANUS HENDERSON GROUP PLC 10.0%
  11. 2025-11-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 3.0%
  12. 2019-09-10 SC 13G · Takeda Pharmaceutical Company Limited 8.1%
Loading e619356_sc13ga-mirum.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…